Skip to content

LIOFeron® TB/LTBI

by Lionex GmbH Germany EUDAMED

Ref LIOFeron 02_22 EMDN W01030601

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR NumberPP07924LIOFERON0240 Basic UDI-DIDate15 Sep 2025RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 23 Oct 2026

Device Name
LIOFeron® HUMAN IFN-γ ELISA
Model / Reference
LIOFeron 02_22
Primary DI / UDI-DI
111761300821
Basic UDI-DI
PP07924LIOFERON0240
EMDN Code
W01030601 INTERFERONS (α, β, ɣ…)
Device Class
Class C
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
DE-MF-000038504

From the manufacturer

Manufacturer's product page: LIOFeron® TB/LTBI

Other devices from Lionex GmbH

Properties & raw data

Show properties, registry sources and raw records
  • Microbial Substances
  • Reagent
  • Professional Testing
Other properties (8)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No

Sources (1)

  • EUDAMED 68bec15d-8e29-4002-87b5-19482dbf0451 61 fields · synced 23 Oct 2026